Predictors of cardiovascular outcome and rehospitalization in elderly patients with heart failure

Gian M Rosa1,2, Riccardo Scagliola1, Paola Ghione1

  • 1Clinic of Cardiovascular Diseases, University of Genoa, Genoa, Italy.

Insights

Predicting heart failure (HF) rehospitalizations in elderly patients requires a comprehensive approach. Combining biochemical, echocardiographic, and socioeconomic factors improves risk stratification and patient quality of life.

Area of Science:

  • Cardiology
  • Geriatrics
  • Public Health

Background:

  • Heart failure (HF) prevalence is increasing, particularly in the elderly.
  • Frequent HF rehospitalizations negatively impact patient quality of life and incur significant healthcare costs.
  • Identifying predictors of HF outcomes and rehospitalizations is crucial for effective management.

Purpose of the Study:

  • To review biochemical, echocardiographic, and socioeconomic parameters as predictors of clinical outcomes and rehospitalizations in heart failure patients.
  • To focus on risk stratification for elderly heart failure patients, a vulnerable population with high readmission rates.

Main Methods:

  • A narrative review of literature published in PubMed from January 2000 to March 2018.
  • Search terms included "elderly, heart failure, cardiovascular" combined with "biomarker, echocardiography, and hospitalization."

Main Results:

  • Analysis of biochemical, echocardiographic, and socioeconomic parameters for predicting cardiovascular outcomes and hospital readmissions in chronic HF.
  • Emphasis on risk stratification for elderly HF patients, identifying them as frail subjects at higher risk for readmission.

Conclusions:

  • A multiparametric approach combining biochemical, echocardiographic, demographic, and socioeconomic parameters is beneficial for risk stratification in elderly chronic HF patients.
  • This integrated approach can enhance patient quality of life and optimize financial resource allocation in healthcare.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319